Loading…
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone
BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the d...
Saved in:
Published in: | British journal of pharmacology 2012-04, Vol.165 (8), p.2549-2560 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273 |
---|---|
cites | cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273 |
container_end_page | 2560 |
container_issue | 8 |
container_start_page | 2549 |
container_title | British journal of pharmacology |
container_volume | 165 |
creator | Olango, WM Roche, M Ford, GK Harhen, B Finn, DP |
description | BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats.
EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone.
KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG.
CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts.
LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7 |
doi_str_mv | 10.1111/j.1476-5381.2011.01478.x |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423235</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3407666471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</originalsourceid><addsrcrecordid>eNqNUUuO1DAQjRCIaQaugCyxTrCdOIkXIMEIGKSRYDGsrYpd6XErbQfbPXTvOAIX4VKcBIeeacEOb1yl9-rV5xUFYbRi-b3cVKzp2lLUPas4ZayiOe-r_YNidQIeFitKaVcy1vdnxZMYN3RhdeJxccaZaBva81Xx8_oGCTrjNTgHg3XeGhIPMeGWWEdSRgMkYnyIfoKEASYyY7DwdYdmp1NO1wEPZIvGZjiSESH8-v5De2dsst6hIeBgWmO0kCNDMpKCn45Mgvs5YIyZeN9uydFpJH4kzmurcU72FknKWk-LRyNMEZ_d_efFl_fvri8uy6tPHz5evLkqtaCsL0dtoAEKRiIfGAeQppVS6tYggxFxNIJLxrgeGiM62st2qMEYraUQIHlXnxevj7rzbsibacwjw6TmYLcQDsqDVf8izt6otb9VdcNrXoss8OJOIPh8qZjUxu9CvkNUTIimkV3Dm8zqjywdfIwBx1MHRtVitNqoxU-1-KkWo9Ufo9U-lz7_e8JT4b2zmfDqSPhmJzz8t7B6-_lyierfa2m_RA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1554497424</pqid></control><display><type>article</type><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><source>Wiley</source><source>PubMed Central</source><creator>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</creator><creatorcontrib>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</creatorcontrib><description>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats.
EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone.
KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG.
CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts.
LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.2011.01478.x</identifier><identifier>PMID: 21564082</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Analgesia ; Animals ; Behavior ; Cannabinoid Receptor Modulators - physiology ; cannabinoid type 1 (CB1) receptor ; Conditioning (Psychology) - physiology ; Endocannabinoids ; fear ; Fear - drug effects ; Fear - physiology ; Formaldehyde ; Male ; Motor Activity - drug effects ; N‐acylethanolamines ; pain ; Pain - chemically induced ; Pain - physiopathology ; Periaqueductal Gray - drug effects ; Periaqueductal Gray - physiology ; periaqueductal grey ; Piperidines - pharmacology ; Pyrazoles - pharmacology ; Rats ; Receptor, Cannabinoid, CB1 - antagonists & inhibitors ; Receptor, Cannabinoid, CB1 - physiology ; Rodents ; Themed Section: Research Papers ; Ultrasonics</subject><ispartof>British journal of pharmacology, 2012-04, Vol.165 (8), p.2549-2560</ispartof><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society</rights><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.</rights><rights>2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</citedby><cites>FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21564082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Olango, WM</creatorcontrib><creatorcontrib>Roche, M</creatorcontrib><creatorcontrib>Ford, GK</creatorcontrib><creatorcontrib>Harhen, B</creatorcontrib><creatorcontrib>Finn, DP</creatorcontrib><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats.
EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone.
KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG.
CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts.
LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</description><subject>Analgesia</subject><subject>Animals</subject><subject>Behavior</subject><subject>Cannabinoid Receptor Modulators - physiology</subject><subject>cannabinoid type 1 (CB1) receptor</subject><subject>Conditioning (Psychology) - physiology</subject><subject>Endocannabinoids</subject><subject>fear</subject><subject>Fear - drug effects</subject><subject>Fear - physiology</subject><subject>Formaldehyde</subject><subject>Male</subject><subject>Motor Activity - drug effects</subject><subject>N‐acylethanolamines</subject><subject>pain</subject><subject>Pain - chemically induced</subject><subject>Pain - physiopathology</subject><subject>Periaqueductal Gray - drug effects</subject><subject>Periaqueductal Gray - physiology</subject><subject>periaqueductal grey</subject><subject>Piperidines - pharmacology</subject><subject>Pyrazoles - pharmacology</subject><subject>Rats</subject><subject>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</subject><subject>Receptor, Cannabinoid, CB1 - physiology</subject><subject>Rodents</subject><subject>Themed Section: Research Papers</subject><subject>Ultrasonics</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqNUUuO1DAQjRCIaQaugCyxTrCdOIkXIMEIGKSRYDGsrYpd6XErbQfbPXTvOAIX4VKcBIeeacEOb1yl9-rV5xUFYbRi-b3cVKzp2lLUPas4ZayiOe-r_YNidQIeFitKaVcy1vdnxZMYN3RhdeJxccaZaBva81Xx8_oGCTrjNTgHg3XeGhIPMeGWWEdSRgMkYnyIfoKEASYyY7DwdYdmp1NO1wEPZIvGZjiSESH8-v5De2dsst6hIeBgWmO0kCNDMpKCn45Mgvs5YIyZeN9uydFpJH4kzmurcU72FknKWk-LRyNMEZ_d_efFl_fvri8uy6tPHz5evLkqtaCsL0dtoAEKRiIfGAeQppVS6tYggxFxNIJLxrgeGiM62st2qMEYraUQIHlXnxevj7rzbsibacwjw6TmYLcQDsqDVf8izt6otb9VdcNrXoss8OJOIPh8qZjUxu9CvkNUTIimkV3Dm8zqjywdfIwBx1MHRtVitNqoxU-1-KkWo9Ufo9U-lz7_e8JT4b2zmfDqSPhmJzz8t7B6-_lyierfa2m_RA</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Olango, WM</creator><creator>Roche, M</creator><creator>Ford, GK</creator><creator>Harhen, B</creator><creator>Finn, DP</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>201204</creationdate><title>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</title><author>Olango, WM ; Roche, M ; Ford, GK ; Harhen, B ; Finn, DP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analgesia</topic><topic>Animals</topic><topic>Behavior</topic><topic>Cannabinoid Receptor Modulators - physiology</topic><topic>cannabinoid type 1 (CB1) receptor</topic><topic>Conditioning (Psychology) - physiology</topic><topic>Endocannabinoids</topic><topic>fear</topic><topic>Fear - drug effects</topic><topic>Fear - physiology</topic><topic>Formaldehyde</topic><topic>Male</topic><topic>Motor Activity - drug effects</topic><topic>N‐acylethanolamines</topic><topic>pain</topic><topic>Pain - chemically induced</topic><topic>Pain - physiopathology</topic><topic>Periaqueductal Gray - drug effects</topic><topic>Periaqueductal Gray - physiology</topic><topic>periaqueductal grey</topic><topic>Piperidines - pharmacology</topic><topic>Pyrazoles - pharmacology</topic><topic>Rats</topic><topic>Receptor, Cannabinoid, CB1 - antagonists & inhibitors</topic><topic>Receptor, Cannabinoid, CB1 - physiology</topic><topic>Rodents</topic><topic>Themed Section: Research Papers</topic><topic>Ultrasonics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Olango, WM</creatorcontrib><creatorcontrib>Roche, M</creatorcontrib><creatorcontrib>Ford, GK</creatorcontrib><creatorcontrib>Harhen, B</creatorcontrib><creatorcontrib>Finn, DP</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Olango, WM</au><au>Roche, M</au><au>Ford, GK</au><au>Harhen, B</au><au>Finn, DP</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>2012-04</date><risdate>2012</risdate><volume>165</volume><issue>8</issue><spage>2549</spage><epage>2560</epage><pages>2549-2560</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><abstract>BACKGROUND AND PURPOSE Endocannabinoids in the midbrain periaqueductal grey (PAG) modulate nociception and unconditioned stress‐induced analgesia; however, their role in fear‐conditioned analgesia (FCA) has not been examined. The present study examined the role of the endocannabinoid system in the dorsolateral (dl) PAG in formalin‐evoked nociceptive behaviour, conditioned fear and FCA in rats.
EXPERIMENTAL APPROACH Rats received intra‐dlPAG administration of the CB1 receptor antagonist/inverse agonist rimonabant, or vehicle, before re‐exposure to a context paired 24 h previously with foot shock. Formalin‐evoked nociceptive behaviour and fear‐related behaviours (freezing and 22 kHz ultrasonic vocalization) were assessed. In a separate cohort, levels of endocannabinoids [2‐arachidonoyl glycerol (2‐AG) and N‐arachidonoyl ethanolamide (anandamide; AEA)] and the related N‐acylethanolamines (NAEs) [N‐palmitoyl ethanolamide (PEA) and N‐oleoyl ethanolamide (OEA)] were measured in dlPAG tissue following re‐exposure to conditioned context in the presence or absence of formalin‐evoked nociceptive tone.
KEY RESULTS Re‐exposure of rats to the context previously associated with foot shock resulted in FCA. Intra‐dlPAG administration of rimonabant significantly attenuated FCA and fear‐related behaviours expressed in the presence of nociceptive tone. Conditioned fear without formalin‐evoked nociceptive tone was associated with increased levels of 2‐AG, AEA, PEA and OEA in the dlPAG. FCA was specifically associated with an increase in AEA levels in the dlPAG.
CONCLUSIONS AND IMPLICATIONS Conditioned fear to context mobilises endocannabinoids and NAEs in the dlPAG. These data support a role for endocannabinoids in the dlPAG in mediating the potent suppression of pain responding which occurs during exposure to conditioned aversive contexts.
LINKED ARTICLES This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue‐8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue‐7</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21564082</pmid><doi>10.1111/j.1476-5381.2011.01478.x</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 2012-04, Vol.165 (8), p.2549-2560 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3423235 |
source | Wiley; PubMed Central |
subjects | Analgesia Animals Behavior Cannabinoid Receptor Modulators - physiology cannabinoid type 1 (CB1) receptor Conditioning (Psychology) - physiology Endocannabinoids fear Fear - drug effects Fear - physiology Formaldehyde Male Motor Activity - drug effects N‐acylethanolamines pain Pain - chemically induced Pain - physiopathology Periaqueductal Gray - drug effects Periaqueductal Gray - physiology periaqueductal grey Piperidines - pharmacology Pyrazoles - pharmacology Rats Receptor, Cannabinoid, CB1 - antagonists & inhibitors Receptor, Cannabinoid, CB1 - physiology Rodents Themed Section: Research Papers Ultrasonics |
title | The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear‐conditioned analgesia and controls fear expression in the presence of nociceptive tone |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A18%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20endocannabinoid%20system%20in%20the%20rat%20dorsolateral%20periaqueductal%20grey%20mediates%20fear%E2%80%90conditioned%20analgesia%20and%20controls%20fear%20expression%20in%20the%20presence%20of%20nociceptive%20tone&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Olango,%20WM&rft.date=2012-04&rft.volume=165&rft.issue=8&rft.spage=2549&rft.epage=2560&rft.pages=2549-2560&rft.issn=0007-1188&rft.eissn=1476-5381&rft_id=info:doi/10.1111/j.1476-5381.2011.01478.x&rft_dat=%3Cproquest_pubme%3E3407666471%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5018-fcda4a0ad9e2b12aa9d6999c6de1afeefd529112cb4d570896b3addcc955a9273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1554497424&rft_id=info:pmid/21564082&rfr_iscdi=true |